156 related articles for article (PubMed ID: 33036421)
1. A SEMA3 Signaling Pathway-Based Multi-Biomarker for Prediction of Glioma Patient Survival.
Valiulyte I; Steponaitis G; Kardonaite D; Tamasauskas A; Kazlauskas A
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036421
[TBL] [Abstract][Full Text] [Related]
2. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
Hu B; Guo P; Bar-Joseph I; Imanishi Y; Jarzynka MJ; Bogler O; Mikkelsen T; Hirose T; Nishikawa R; Cheng SY
Oncogene; 2007 Aug; 26(38):5577-86. PubMed ID: 17369861
[TBL] [Abstract][Full Text] [Related]
4. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins.
Rieger J; Wick W; Weller M
Glia; 2003 Jun; 42(4):379-89. PubMed ID: 12730958
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
Wang LQ; Sun W; Wang Y; Li D; Hu AM
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
Karayan-Tapon L; Wager M; Guilhot J; Levillain P; Marquant C; Clarhaut J; Potiron V; Roche J
Br J Cancer; 2008 Oct; 99(7):1153-60. PubMed ID: 18781179
[TBL] [Abstract][Full Text] [Related]
7. The role of the plexin-A2 receptor in Sema3A and Sema3B signal transduction.
Sabag AD; Smolkin T; Mumblat Y; Ueffing M; Kessler O; Gloeckner CJ; Neufeld G
J Cell Sci; 2014 Dec; 127(Pt 24):5240-52. PubMed ID: 25335892
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma.
Osada H; Tokunaga T; Nishi M; Hatanaka H; Abe Y; Tsugu A; Kijima H; Yamazaki H; Ueyama Y; Nakamura M
Anticancer Res; 2004; 24(2B):547-52. PubMed ID: 15160992
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of plexins signaling in glioma progression and therapy.
Angelopoulou E; Piperi C
Cancer Lett; 2018 Feb; 414():81-87. PubMed ID: 29133239
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.
Tominaga K; Minato H; Murayama T; Sasahara A; Nishimura T; Kiyokawa E; Kanauchi H; Shimizu S; Sato A; Nishioka K; Tsuji EI; Yano M; Ogawa T; Ishii H; Mori M; Akashi K; Okamoto K; Tanabe M; Tada KI; Tojo A; Gotoh N
Proc Natl Acad Sci U S A; 2019 Jan; 116(2):625-630. PubMed ID: 30587593
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
[TBL] [Abstract][Full Text] [Related]
14. Identification of an ATP metabolism-related signature associated with prognosis and immune microenvironment in gliomas.
Huang R; Li G; Wang Z; Hu H; Zeng F; Zhang K; Wang K; Wu F
Cancer Sci; 2020 Jul; 111(7):2325-2335. PubMed ID: 32415873
[TBL] [Abstract][Full Text] [Related]
15. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival.
Yoshida Y; Nakada M; Sugimoto N; Harada T; Hayashi Y; Kita D; Uchiyama N; Hayashi Y; Yachie A; Takuwa Y; Hamada J
Int J Cancer; 2010 May; 126(10):2341-52. PubMed ID: 19810093
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Chen W; Yu Q; Chen B; Lu X; Li Q
Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
[TBL] [Abstract][Full Text] [Related]
18. FGF2 as a potential prognostic biomarker for proneural glioma patients.
Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
[TBL] [Abstract][Full Text] [Related]
19. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer.
Müller MW; Giese NA; Swiercz JM; Ceyhan GO; Esposito I; Hinz U; Büchler P; Giese T; Büchler MW; Offermanns S; Friess H
Int J Cancer; 2007 Dec; 121(11):2421-33. PubMed ID: 17631638
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
Zhang J; Lv J; Zhang F; Che H; Liao Q; Huang W; Li S; Li Y
J Neurooncol; 2017 Jul; 133(3):553-559. PubMed ID: 28551850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
